Aasthaa Bansal, PhD
Joint Assistant Member, Public Health Sciences Division
Research Assistant Professor, School of Pharmacy, University of Washington
Dr. Bansal uses statistical methods for comparative effectiveness and outcomes research, and for the development and evaluation of biomarkers using censored survival data.
Anirban Basu, PhD
Associate Professor, Departments of Pharmacy & Health Services, University of Washington
Adjunct Associate Professor, Economics, University of Washington
Adjunct Associate Professor, Pharmacy, University of Washington
Dr. Basu’s research interests include methods and applications that study observed and unobserved heterogeneity in clinical and economic outcomes.
Josh Carlson, PhD
Associate Professor, Department of Pharmacy, University of Washington
Dr. Carlson's current research interests and work to date has primarily focused on the intersection of three areas: 1) genomics and emerging technologies in the field of personalized medicine, 2) uncertainty both in our decision-making processes in "real world" settings 3) improvement of health and healthcare economic and policy options to improve.
Rachel Issaka, MD, MAS
Joint Assistant Member, Clinical Research Division and Public Health Sciences Division, Fred Hutch
Assistant Professor, Gastroenterology & Hepatology, University of Washington Dr. Issaka is a gastroenterologist who specializes in the medical and endoscopic management of digestive diseases including cancer related complications that affect the gastrointestinal system. Her research focuses on: (1) understanding patient barriers and facilitators to colorectal cancer screening, (2) determining the factors that influence colonoscopy completion following abnormal stool-based screening tests, and (3) identifying gaps in care to implement interventions that improve the quality of cancer control and prevention, particularly in minority populations.
Salene Jones, PhD
Assistant Member, Public Health Sciences Division, Fred Hutch
Dr. Jones is a psychometrician and psychologist whose research focuses on survey and questionnaire development. She also studies the psychological and environmental factors that influence distress and quality of life in people with cancer.
Richard Kim, MD
Senior Fellow, Pulmonary and Critical Care Medicine, University of Washington School of Medicine
Dr. Kim is a senior fellow in pulmonary/critical care medicine who sees patients with lung diseases and suspected lung cancer at the Seattle Cancer Care Alliance. His primary research focus is on the cost of lung cancer diagnosis.
Christoph Lee, MD, MS
Associate Professor, Radiology, University of Washington School of Medicine
Adjunct Associate Professor, Health Services, University of Washington School of Public Health
Dr. Lee's research focuses on new imaging-based cancer screening technologies and appropriate use of advanced imaging in the cancer care continuum, with expertise in cost-effectiveness analysis and technology assessment.
Janie M. Lee, MD, MSc
Associate Professor, University of Washington
Clinical Director, Breast Imaging, Seattle Cancer Care Alliance
Dr. Lee's research focuses on integrating information about patient risk factors, cancer biology, and emerging technologies to develop more personalized breast cancer screening and surveillance regimens and to improve population level outcomes.
Cara McDermott, PharmD, PhD, MSc
Senior Fellow, Cambia Palliative Care Center of Excellence, University of Washington School of Medicine
Dr. McDermott's interests include health economics and comparative effectiveness research, with a particular focus on cancer, end-of-life care, and geriatrics.
Laura Panattoni, PhD
Staff Scientist, Public Health Sciences Division, Fred Hutch
Dr. Panattoni's research interests include health information technology, economic evaluation, cost methodology, and health economics.
Shilpen Patel, MD
Associate Professor, Department of Radiation Oncology, University of Washington
Radiation Oncologist, University of Washington Medical Center
Radiation Oncologist, SCCA Proton Therapy Center
Dr. Patel is a radiation oncologist who specializes in the treatment of thoracic cancer, including lung, thymic, and tracheal tumors, gastrointestinal cancers, and chest sarcoma.
Joshua A. Roth, PhD, MHA
Assistant Member, Public Health Sciences Division, Fred Hutch
Dr. Roth is a comparative effectiveness researcher with a background in health economics, epidemiology, and health services management. His research interests include application of regression modeling, meta-analysis, and decision modeling to evaluate chronic disease health outcomes.
Veena Shankaran, MD, MS
Joint Associate Member, Clinical Research Division and Public Health Sciences Division, Fred Hutch Associate Professor, Medical Oncology, University of Washington School of Medicine
Dr. Shankaran is a medical oncologist who specializes in caring for patients with gastrointestinal malignancies, with a particular focus on cancers of the esophagus and stomach. Her research expertise includes health economics and comparative effectiveness, with a focus on patterns of care and risk factors for financial hardship among cancer patients.
Lotte Steuten, PhD, MSc
Associate Member, Public Health Sciences Division, Fred Hutch
Dr. Steuten is a health economist with a background in health services research. Her work focuses on the development and application of methods for early cycle health economic evaluation – mainly conducted in the research and development phase – to help innovators focus on new treatments and medical technologies against cancer that are likely to be cost-effective, have the highest ROI and greatest impact on health.
Sean D. Sullivan, PhD, MS
Professor and Dean, School of Pharmacy, University of Washington
Dr. Sullivan's research interests include technology assessment; medical decision-making; economic evaluation of health care technologies, particularly in the areas of respiratory disorders, cancer, and HCV.
David Veenstra, PharmD, PhD
Professor, School of Pharmacy, University of Washington
Dr. Veenstra’s research interests include clinical, economic, and policy implications of using genomic information in healthcare.